http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-146147-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1788b29c1371c03e2a198fdeb4a0971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e473e6596e67849fbdfc0991bfd02ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afbb191104e4d5a32d5ee45f218127cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47320ce13b69d11574dc881089d64d09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d6f38f86c99b776f3f3c09eaed2d7b5
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
filingDate 1979-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4771a8a30ee5392c4073c07cb7b25e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f51f3165b5defa5ff9a2c3750bafdc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b117da469f3478941adbea66a99f45a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2fd9eddfdaff9e321a99a8fbdb23bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b66d3d95b52f3511676739b3a998c6c9
publicationDate 1981-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-146147-A1
titleOfInvention PROCESS FOR PREPARING INACTIVATED ANTIGENES
abstract Area: Technical Virology and Microbiology. The aim is to produce inactivated antigens and related substances, especially inactive vaccines, without significant loss of antigen or activity, without the addition of chemical agents and without time-consuming intermediate storage. The object of producing inactivated antigens and corresponding preparations without significant antigen or yield losses is achieved by subjecting viruses or microorganisms to ionizing radiation treatment without altering the usual media used in the preparation of antigens and corresponding preparations. Active viruses or microorganisms are exposed to ionizing radiation without the addition of special chemical agents and without time-consuming intermediate storage. In the case of a gamma irradiation, this is preferably done in the area of 0.8 to 1.6 billion also directly in the end-of-the-world ballast. In this specific treatment, no significant activity or antigen losses occur. Possible Applications: Vaccine and drug production including the preparation of special test preparations.
priorityDate 1979-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO72120
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27405
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36284
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP89681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90590
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36285
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DOK3
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19192
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415788865
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61492
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9INJ1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559375
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEI6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27406
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW6JHZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9G059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27404

Total number of triples: 42.